FDA
approval
· 2023-12-15
FDA Approved: BUPRENORPHINE HCL AND NALOXONE HCL — Supplemental Application (Amneal Pharmaceuticals LLC)
Summary
FDA approved Amneal's supplemental application for a generic buprenorphine HCl and naloxone HCl product for opioid use disorder. This is an approval of a supple…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for BUPRENORPHINE HCL AND NALOXONE HCL (BUPRENORPHINE AND NALOXONE)